Tandem Diabetes Care (TNDM) Consolidated Net Income (2013 - 2026)
Tandem Diabetes Care posted quarterly Consolidated Net Income of -$20.4 million for Q1 2026, up 84.38% year-on-year from -$11.1 million in Q1 2025, and down 3655.62% on a QoQ basis from -$543000.0 in Q4 2025.
Tandem Diabetes Care (TNDM) has 14 years of Consolidated Net Income data on file, last reported at -$20.4 million in Q1 2026.
- For the quarter ending Q1 2026, Consolidated Net Income rose 84.38% year-over-year to -$20.4 million; the trailing twelve-month figure through Mar 2026 stood at -$94.5 million (up 48.59% YoY), and the FY2025 full-year result was -$204.7 million, down 113.18% from the prior year.
- Consolidated Net Income for Q1 2026 stood at -$20.4 million, down from -$543000.0 in the prior quarter.
- Across five years, Consolidated Net Income topped out at $769000.0 in Q4 2024 and bottomed at -$130.6 million in Q1 2025.
- The 5-year median for Consolidated Net Income is -$30.0 million (2023), against an average of -$37.5 million.
- The widest annual swing landed in 2022, when Consolidated Net Income plunged 951.95%; it then jumped 102.56% in 2024.
- A 5-year view of Consolidated Net Income shows it stood at -$15.9 million in 2022, then sank by 89.31% to -$30.0 million in 2023, then soared by 102.56% to $769000.0 in 2024, then slumped by 170.61% to -$543000.0 in 2025, then plunged by 3655.62% to -$20.4 million in 2026.
- The last three Consolidated Net Income figures came in at -$20.4 million (Q1 2026), -$543000.0 (Q4 2025), and -$21.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Tandem Diabetes Care | 1.31 Bn | 739.55 Mn | 136.79 Mn | -20.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.39 Mn |
| Dec 31, 2025 | -543,000.00 |
| Sep 30, 2025 | -21.14 Mn |
| Jun 30, 2025 | -52.42 Mn |
| Mar 31, 2025 | -130.56 Mn |
| Dec 31, 2024 | 769,000.00 |
| Sep 30, 2024 | -23.21 Mn |
| Jun 30, 2024 | -30.81 Mn |
| Mar 31, 2024 | -42.73 Mn |
| Dec 31, 2023 | -30.01 Mn |
| Sep 30, 2023 | -32.90 Mn |
| Jun 30, 2023 | -35.70 Mn |
| Mar 31, 2023 | -123.87 Mn |
| Dec 31, 2022 | -15.85 Mn |
| Sep 30, 2022 | -48.97 Mn |
| Jun 30, 2022 | -15.05 Mn |
| Mar 31, 2022 | -14.70 Mn |
| Dec 31, 2021 | 10.76 Mn |
| Sep 30, 2021 | 5.75 Mn |
| Jun 30, 2021 | 4.01 Mn |
| Mar 31, 2021 | -5.06 Mn |
| Dec 31, 2020 | 17.00 Mn |
| Sep 30, 2020 | -9.41 Mn |
| Jun 30, 2020 | -29.20 Mn |
| Mar 31, 2020 | -14.87 Mn |
| Dec 31, 2019 | 2.65 Mn |
| Sep 30, 2019 | -2.90 Mn |
| Jun 30, 2019 | -1.51 Mn |
| Mar 31, 2019 | -22.99 Mn |
| Dec 31, 2018 | 3.69 Mn |
| Sep 30, 2018 | -34.25 Mn |
| Jun 30, 2018 | -13.70 Mn |
| Mar 31, 2018 | -15.39 Mn |
| Dec 31, 2017 | -9.52 Mn |
| Sep 30, 2017 | -13.11 Mn |
| Jun 30, 2017 | -18.91 Mn |
| Mar 31, 2017 | -21.17 Mn |
| Dec 31, 2016 | -13.31 Mn |
| Sep 30, 2016 | -28.38 Mn |
| Jun 30, 2016 | -16.95 Mn |
| Mar 31, 2016 | -19.12 Mn |
| Dec 31, 2015 | -11.13 Mn |
| Sep 30, 2015 | -18.62 Mn |
| Jun 30, 2015 | -18.61 Mn |
| Mar 31, 2015 | -20.31 Mn |
| Dec 31, 2014 | -17.47 Mn |
| Sep 30, 2014 | -18.98 Mn |
| Jun 30, 2014 | -18.29 Mn |
| Mar 31, 2014 | -20.82 Mn |
| Dec 31, 2013 | -16.46 Mn |
| Sep 30, 2013 | -12.13 Mn |
| Jun 30, 2013 | -13.68 Mn |
| Mar 31, 2013 | -7.17 Mn |